SAHPRA MedSafetyWeek campaign: Reporting of Side Effects

By Staff Writer

November 11, 2023

The Importance of Documenting Side Effects

The South African Health Products Regulatory Authority (SAHPRA) is advocating for the usage of the MedSafety app as a means of bolstering efforts to ensure the integrity of medicinal products. #MedSafetyWeek is a global campaign that aims to improve the safety of medications all around the world, and this project is a component of that campaign. The campaign, involving more than 80 regulatory agencies, is a testament to the collective effort to better the healthcare industry.

 

SAHPRA MedSafetyWeek campaign: A Tool for Safer Medicines

Patients, physicians, nurses, and pharmacists are all able to report adverse effects with the help of a powerful tool called the MedSafety app. These reports are absolutely necessary for the continuous monitoring of the medications’ safety. According to Mafora Matlala, the Pharmacovigilance Manager at SAHPRA, “Every report is important in building more knowledge and understanding of the benefits and risks of medicines in clinical use and allows action to be taken to minimise risks.”

Users can download the MedSafety app from the Google Play Store or the Apple App Store, depending on your device. The app allows users to report adverse events and product quality issues. This helps enhance the safety of the healthcare environment overall.

SAHPRA’s commitment to the safety, efficacy, and quality of all health products underlines its ethos. Together, we can make a difference in ensuring safer medicines for all.

Reference url

Recent Posts

robotic surgery approval
               

NICE Grants Conditional Robotic Surgery Approval to Enhance Patient Care and Address Health Inequities

🤖 Are you ready for the future of surgery?

The recent approval of 11 robotic surgery systems by NICE could improve patient care in the NHS, leading to faster recoveries and minimal invasiveness. With a focus on real-world evidence, this transformative step aims to improve health outcomes while addressing access and equity concerns.

Explore how this innovative approach will shape the landscape of surgical procedures in the coming years!

#SyenzaNews #HealthcareInnovation #MedicalDevices #MarketAccess

sugary drinks cancer risk
        

Sugary Drinks Cancer Risk: Women Face Higher Oral Cavity Cancer Threat

💡 Are sugary drinks putting your health at risk?

Recent research highlights a staggering link between sugary beverage consumption and an increased risk of oral cavity cancer in women. With those consuming just one sugary drink per week facing nearly five times higher odds of developing this cancer, it’s crucial to reevaluate our dietary choices and their health implications.

Jump into the findings and discover how this modifiable risk factor could reshape public health strategies and clinical practices.

#SyenzaNews #oncology #HealthTech #healthcarepolicy

CAB–LA cost-effectiveness
    

Cost-Effective HIV PrEP: CAB-LA Transforms Prevention

💡 Can CAB-LA revolutionize HIV prevention for underserved communities?

A new study confirms CAB-LA’s cost-effectiveness as HIV PrEP, preventing 4.5 more infections per 100 users than oral PrEP and saving $42,517 in healthcare costs. It significantly benefits African American/Black MSM and cisgender women, aligning with EHE goals.

Explore how CAB-LA reshapes HIV prevention! Read the full article.

#SyenzaNews #HealthEconomics #HealthcareInnovation #CostEffectiveness

When you partner with Syenza, it’s like a Nuclear Fusion.

Our expertise are combined with yours, and we contribute clinical expertise and advanced degrees in health policy, health economics, systems analysis, public finance, business, and project management. You’ll also feel our high-impact global and local perspectives with cultural intelligence.

SPEAK WITH US

CORRESPONDENCE ADDRESS

1950 W. Corporate Way, Suite 95478
Anaheim, CA 92801, USA

© 2025 Syenza™. All rights reserved.